Published in Br J Cancer on October 01, 1996
Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG. Infect Immun (2008) 1.04
Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma. J Hepatocell Carcinoma (2014) 0.75
Enhancement of tumor cell susceptibility to tumor-infiltrating lymphocytes by cisplatin. J Cancer Res Clin Oncol (1997) 0.75
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41
Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J Exp Med (1982) 9.49
A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science (1986) 8.07
Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J Exp Med (1984) 6.45
Cloning of the gamma chain of the human IL-2 receptor. Science (1992) 4.50
Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science (1993) 4.39
B-cell stimulatory factor-1/interleukin 4. Annu Rev Immunol (1987) 4.04
High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells. J Exp Med (1986) 2.37
The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. Science (1987) 2.35
Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor. J Exp Med (1987) 2.15
Recombinant interleukin 4 promotes the growth of human T cells. J Immunol (1987) 2.13
Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J Exp Med (1988) 1.98
Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J Immunol (1985) 1.93
In vivo thymocyte maturation. BUdR labeling of cycling thymocytes and phenotypic analysis of their progeny support the single lineage model. J Immunol (1986) 1.88
Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J Clin Oncol (1988) 1.46
The role of IL4 and IL5: characterization of a distinct helper T cell subset that makes IL4 and IL5 (Th2) and requires priming before induction of lymphokine secretion. Immunol Rev (1988) 1.44
Interleukin-4 mediates CD8 induction on human CD4+ T-cell clones. Nature (1988) 1.41
The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. J Immunol (1988) 1.38
The differentiation of T lymphocytes. V. Evidence for intrathymic death of most thymocytes. Thymus (1979) 1.37
Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells. J Exp Med (1987) 1.35
Activation of peripheral blood T cells via the p75 interleukin 2 receptor. J Exp Med (1989) 1.25
IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. J Immunol (1989) 1.12
IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity. J Immunol (1988) 1.08
Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. Br J Cancer (1990) 0.96
Interactions between receptors for interleukin 2 and interleukin 4 on lines of helper T cells (HT-2) and B lymphoma cells (BCL1). J Exp Med (1989) 0.95
Promotion of human T lymphocyte proliferation by IL-4. J Immunol (1989) 0.94
Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas. Cancer Immunol Immunother (1986) 0.94
Interleukin-2 receptor heterotrimer complex and intracellular signaling. Semin Immunol (1993) 0.93
IL-5 up-regulates but IL-4 down-regulates IL-2R expression on a cloned B lymphoma line. J Immunol (1990) 0.90
Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors. Int J Cancer (1990) 0.87
Functional and phenotypic analyses of interleukin 2-activated tumor-infiltrating lymphocytes. Biotherapy (1990) 0.86
Characterization of activated lymphocytes in colon cancer. Clin Immunol Immunopathol (1989) 0.86
A bidirectional regulatory network involving IL 2 and IL 4 in the alternative CD2 pathway of T cell activation. Eur J Immunol (1990) 0.86
Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4. J Immunother Emphasis Tumor Immunol (1993) 0.80
In vitro augmentation of the cytotoxic activity of peripheral blood mononuclear cells and tumor-infiltrating lymphocytes by famotidine in cancer patients. Int J Immunopharmacol (1992) 0.79
The promotive effect of interleukin 4 with interleukin 2 in the proliferation of tumor-infiltrating lymphocytes from patients with malignant tumor. Biotherapy (1992) 0.78
An autoreactive T cell clone generated in the autologous mixed lymphocyte reaction in a patient with gastric carcinoma. J Clin Lab Immunol (1993) 0.77
Peripheral blood and tumor infiltrating lymphocytes in non-small cell lung cancer: analysis at the population and clonal level. Tumori (1990) 0.77
IL-4 down-regulates IL-2 receptor p75 by accelerating its endocytosis. Int Immunol (1991) 0.77
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A (1997) 7.08
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci (1992) 4.39
Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci (2000) 3.73
Clinical features and management of hepatic portal venous gas: four case reports and cumulative review of the literature. Arch Surg (2001) 3.66
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest (1999) 3.21
Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J (1993) 2.69
Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A (1994) 2.43
Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol (2001) 1.95
Unusual widening of Virchow-Robin spaces: MR appearance. AJNR Am J Neuroradiol (1995) 1.92
Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci U S A (1993) 1.92
Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene (1998) 1.92
gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev (2000) 1.89
Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol (1997) 1.88
Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol (1996) 1.84
Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J Biol Chem (1999) 1.83
Treatment of esophageal and gastric tumors. Endoscopy (1999) 1.75
Transfer of ciprofloxacin to bile and determination of biliary metabolites in humans. Arzneimittelforschung (1986) 1.75
Expression of a homeo domain protein in noncontact-inhibited cultured cells and postmitotic neurons. Genes Dev (1987) 1.74
Age-related volumetric changes of brain gray and white matter in healthy infants and children. Cereb Cortex (2001) 1.69
Stem cell properties of human periodontal ligament cells. J Periodontal Res (2006) 1.64
Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev (2000) 1.61
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol (2001) 1.57
Dapsone in the treatment of miliary lupus of the face. Br J Dermatol (1983) 1.57
Hypersensitivity pneumonitis induced by toluene diisocyanate: sequelae of continuous exposure. Ann Intern Med (1989) 1.53
Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. Gastroenterology (1992) 1.52
Brain-derived neurotrophic factor increases in the uninjured dorsal root ganglion neurons in selective spinal nerve ligation model. J Neurosci (2001) 1.50
Tumors of peripheral nerves: correlation of symptoms, clinical signs, imaging features, and histologic diagnosis. Skeletal Radiol (1999) 1.49
High-performance liquid chromatographic assay of serum glycated albumin. Diabetologia (1988) 1.47
Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain. Proc Natl Acad Sci U S A (1996) 1.45
Randomized clinical trial of isolated Roux-en-Y versus conventional reconstruction after pancreaticoduodenectomy. Br J Surg (2014) 1.44
Bone formation in vitro and in nude mice by human osteosarcoma cells. Virchows Arch (1995) 1.42
Endoscopic treatment of early oesophageal or gastric cancer. Gut (1997) 1.42
Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. J Immunol (2001) 1.41
Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neurosci Lett (1996) 1.40
Hair follicle nevus. Dermatology (1992) 1.39
Common variable immunodeficiency with unusual vegetative lesions of the tongue and labial mucosa: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2001) 1.39
Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem Biophys Res Commun (1990) 1.39
Cerebral aneurysms: evaluation with three-dimensional CT angiography. AJNR Am J Neuroradiol (1996) 1.36
Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4. Drug Metab Dispos (1998) 1.35
Male-to-female sex reversal in M33 mutant mice. Nature (1998) 1.35
Functional domains of Pho81p, an inhibitor of Pho85p protein kinase, in the transduction pathway of Pi signals in Saccharomyces cerevisiae. Mol Cell Biol (1995) 1.33
Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem Biophys Res Commun (1995) 1.28
Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun (1995) 1.26
Insulin as a potent, specific growth factor in a rat hepatoma cell line. Science (1981) 1.24
Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene (1999) 1.23
Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation? Trends Neurosci (1998) 1.22
Change in mRNAs for neuropeptides and the GABA(A) receptor in dorsal root ganglion neurons in a rat experimental neuropathic pain model. Pain (1998) 1.22
Ex vivo generation of CD34(+) cells from CD34(-) hematopoietic cells. Blood (1999) 1.21
The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. FEBS Lett (1999) 1.21
Laparoscope-assisted Billroth I gastrectomy. Surg Laparosc Endosc (1995) 1.20
Spontaneous rupture of craniopharyngioma cysts. A report of five cases and review of the literature. Surg Neurol (1993) 1.19
In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology (1998) 1.19
Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev (1996) 1.19
Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene (1997) 1.19
Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J Neurosci Res (1998) 1.19
The promoter proximal region in the virD locus of Agrobacterium tumefaciens is necessary for the plant-inducible circularization of T-DNA. Mol Gen Genet (1987) 1.18
Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med (1997) 1.18
The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood (1994) 1.18
Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report. Ophthalmology (2001) 1.18
Microwave surgery: hepatectomy using a microwave tissue coagulator. World J Surg (1985) 1.17
A gigantic neurilemoma originating in the pterygopalatine fossa. Case report. Surg Neurol (1988) 1.17
Interleukin 2 receptors on cultured murine epidermal Langerhans cells. J Immunol (1986) 1.16
Leu-3/T4 expression on epidermal Langerhans cells in normal and diseased skin. J Invest Dermatol (1986) 1.16
Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation. J Pharmacol Exp Ther (1993) 1.16
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. Ann Oncol (2006) 1.16
Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells. Blood (1987) 1.15
Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Cancer Chemother Pharmacol (1992) 1.15
Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice. Eur J Immunol (1986) 1.15
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. Ann Oncol (2008) 1.14
The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci (1998) 1.13
Differential regulation of P2X(3) mRNA expression by peripheral nerve injury in intact and injured neurons in the rat sensory ganglia. Pain (2001) 1.12
Lipopolysaccharide-induced colitis in rabbits. Res Exp Med (Berl) (1986) 1.11
Operations for forearm deformity caused by multiple osteochondromas. J Bone Joint Surg Br (1989) 1.11
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. Br J Cancer (2004) 1.10
Percutaneous microwave tissue coagulation in liver biopsy: experimental and clinical studies. Nihon Geka Hokan (1986) 1.10
Passive smoking by pregnant women and fetal growth. J Epidemiol Community Health (1991) 1.09
Contraction characteristics and ATPase activity of skeletal muscle fibers in the presence of antibody to myosin subfragment 2. Proc Natl Acad Sci U S A (1992) 1.09
Molecular cloning of a novel NF2/ERM/4.1 superfamily gene, ehm2, that is expressed in high-metastatic K1735 murine melanoma cells. Genomics (2000) 1.09
Ice storm damage and early recovery in an old-growth forest. Environ Monit Assess (2001) 1.08
Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia. Skeletal Radiol (2001) 1.08
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica (2001) 1.08
Systemic and cutaneous plasmacytosis with multiple skin lesions and polyclonal hypergammaglobulinaemia: significant serum interleukin-6 levels. Br J Dermatol (1992) 1.07
IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol (1996) 1.06
Role of sympathovagal balance in the initiation of idiopathic ventricular tachycardia originating from right ventricular outflow tract. Pacing Clin Electrophysiol (1997) 1.06
[Activation analysis of mercury in head hair of dentists (author's transl)]. Radioisotopes (1980) 1.06
Brain metastases in musculoskeletal sarcomas. Jpn J Clin Oncol (1999) 1.06
Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res (1981) 1.06
Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney. J Biol Chem (2001) 1.06
Expression of CD90 on keratinocyte stem/progenitor cells. Br J Dermatol (2006) 1.06
A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study). Eur J Surg Oncol (2010) 1.06
Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects. Clin Obes (2012) 1.05
Multiple schwannomas in the peripheral nerves. J Bone Joint Surg Br (1998) 1.05
Myxoid liposarcoma metastatic to the thoracic epidural space without bone involvement: report of two cases. Jpn J Clin Oncol (2001) 1.05
Overexpression of the MDM2 oncogene in leukemia and lymphoma. Leuk Lymphoma (1996) 1.05
Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol (1998) 1.04